Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Is high-dose glucocorticoid beneficial in COVID-19?
Valliappan Muthu, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Ritesh Agarwal
Eur Respir J, 57 (4) 2100065; 10.1183/13993003.00065-2021
Airway diseases, Respiratory critical care
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Valliappan Muthu, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Ritesh Agarwal. Is high-dose glucocorticoid beneficial in COVID-19?. Eur Respir J, 57 (4) 2100065; 10.1183/13993003.00065-2021
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Reply: Is high-dose glucocorticoid beneficial in COVID-19?
Source: Eur Respir J, 57 (4) 2100324; 10.1183/13993003.00324-2021
The efficacy of steroid with pentoxifylline in steroid resistant sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 542s
Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD
Source: Eur Respir J, 53 (2) 1802420; 10.1183/13993003.02420-2018
Long-term oral corticosteroid-sparing effects of anti-IL5/anti-IL5 receptor treatment.
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Does selenium long-term therapy restore hypothalamic-pituitary-adrenal axis in oral steroids dependant patients?
Source: Annual Congress 2009 - Asthma and comorbid conditions
Investigating the steroids and long-acting β2-agonists combination: why do we need more?
Source: Eur Respir J 2004; 23: 501-502
Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where?
Source: Eur Respir J 2011; 38: 947-958
Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma?
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma?
Source: Eur Respir J 2001; 17: 1059-1061
Mechanisms of systemic side effects of inhaled steroids
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Muscle regrowth in COPD patients induced by anabolic steroids is amplified by systemic glucocorticoids (GC): A potentiating interaction between GC and IGF-1?
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma
Source: Eur Respir J, 55 (1) 1901147; 10.1183/13993003.01147-2019
Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids
Source: Eur Respir J 2006; 27: 511-516
Combination of pentoxifylline and steroids in sarcoidosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 269s
Low-dose inhaled glucocorticoids are more effective tham LTRA in improving functional data in asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 126s
Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids
Source: Annual Congress 2007 - Respiratory issues in primary care
Anti-inflammatory effects of add-on atorvastatin therapy during the treatment of COPD patients
Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
Source: Eur Respir Rev 2015; 25: 54-64